Independent community pharmacist interest in participating in community pharmacy research networks

Journal of the American Pharmacists Association

Volumn 51, Issue 6, 2011, Pages 727-738

  Carr, Molly B ^a   Divine, Holly ^b   Hanna, Cathy ^c   Freeman, Patricia R ^b   Blumenschein, Karen ^b  

^a CVS Caremark   (United States)

^b University of Kentucky   (United States)

^c American Pharmacy Services Corporation   (United States)

Author keywords

Community pharmacy; Community pharmacy research networks; Practice based research networks

Indexed keywords

ARTICLE; DESCRIPTIVE RESEARCH; EXPLORATORY RESEARCH; HOSPITAL DEPARTMENT; HUMAN; LEARNING; PARTICIPATORY RESEARCH; PHARMACIST; PHARMACY; PROFESSIONAL PRACTICE; UNITED STATES; ADULT; AGED; COOPERATION; FEMALE; HEALTH SERVICES RESEARCH; INFORMATION PROCESSING; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; COMMUNITY-BASED PARTICIPATORY RESEARCH; COOPERATIVE BEHAVIOR; DATA COLLECTION; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; KENTUCKY; MALE; MIDDLE AGED; PHARMACISTS;

EID: 84857484916     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2011.10099     Document Type: Article

References (16)

1. Agency for Healthcare Research and Quality. AHRQ support for primary care practice-based research networks (PBRNs): fact sheet. Accessed at www.ahrq.gov/research/pbrn/pbrnfact.htm, October 16, 2009.
2. Goode JV, Mott DA, Chater R. Collaborations to facilitate success of community pharmacy practice-based research networks. J Am Pharm Assoc. 2008;48:153-62.
3. Lipowski EE. Pharmacy practice-based research networks: why, what, who, and how. J Am Pharm Assoc. 2008;48:142-52.
4. University of Minnesota College of Pharmacy. Collaborating to improve patient care: Minnesota Pharmacy Practice-Based Research Network. Accessed at www.pharmacy.umn.edu/news/PBRN-arstory/home.html, August 1, 2011.
5. Blumenschein K, Johannesson M, Yokoyama KK, Freeman PR. Hypothetical versus real willingness to pay in the health sector: results from a field experiment. J Health Econ. 2001;20;441-57.
6. Zillich AJ, Blumenschein K, Johannesson M, Freeman P. Assessment of the relationship between objective measures of disease severity, quality of life and willingness to pay in asthma. Pharmacoeconomics. 2002;20:257-65.
7. Moy ML, Fuhlbrigge AL, Blumenschein K, et al. Association between preference-based health-related quality of life and asthma severity. Ann Allergy Asthma Immunol. 2004;92:329-34.
8. Blumenschein K, Blomquist GC, Johannesson M, et al. Eliciting willingness to pay without bias: evidence from a field experiment. The Economic Journal. 2008;118(Jan):114-37.
9. Blomquist GC, Blumenschein K, Johannesson M. Eliciting willingness to pay without bias using follow-up certainty statements: comparison between probably/definitely and a 10-point certainty scale. Environmental & Resource Economics. 2009;43(Aug):473-502.
10. Marinac JS, Kuo GM. Characterizing the American College of Clinical Pharmacy practice-based research network. Pharmacotherapy. 2010;30:865.
11. Slabaugh L, Freeman PR, Garces H, Blumenschein K. Participation in community pharmacy networks: results for a survey in Kentucky [abstract]. Am J Health Syst Pharm. 2008;65:20
12. National Community Pharmacists Association. 2009 NCPA Digest. Accessed at www.ncpanet.org/pdf/digest/digest09-financials.pdf, April 19, 2010.
13. American Pharmacy Services Corporation. Homepage. Accessed at www.apscnet.com, April 19, 2010.
14. Wendel E. Pharmacists survey gives insight into the impact of the economic downturn on patients, pharmacy practice, and their communities. Accessed at www.pharmacist.com/AM/Template.cfm?Section=News- Releases2&template=/CM/ContentDisplay. cfm&ContentID=18987, September 21, 2010.
15. Midwest Pharmacy Workforce Research Consortium. National Pharmacist Workforce Survey. Accessed at www.aacp.org/resources/research/pharmacymanpower/ Documents/finalreport. pdf, September 21, 2010.
16. Goyal RK, Patel JG, Sansgiry SS. Pharmacists perceptions of drug reimbursement rates and processing times among managed care plans. Drug Benefit Trends. 2010;22(4):116-20.